M&A Deal Summary

Certara Acquires Synchrogenix Information Strategies

On April 2, 2014, Certara acquired medical products company Synchrogenix Information Strategies

Acquisition Highlights
  • This is Certara’s 1st transaction in the Medical Products sector.
  • This is Certara’s 2nd transaction in the United States.
  • This is Certara’s 1st transaction in Delaware.

M&A Deal Summary
Date 2014-04-02
Target Synchrogenix Information Strategies
Sector Medical Products
Buyer(s) Certara
Deal Type Add-on Acquisition

Target

Synchrogenix Information Strategies

Wilmington, Delaware, United States
Synchrogenix partners with pharmaceutical and biotech companies to develop submission documents for global regulatory agencies.

Search 200,291 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Certara

Princeton, New Jersey, United States
Category Company
Founded 2008
Sector Life Science
Employees1,338
Revenue 354M USD (2023)
DESCRIPTION

Certara engages in model-informed drug development and regulatory science, focused on optimizing drug development and improving health outcomes. Certara was founded in 2008 and is headquartered in Princeton, New Jersey.

DEAL STATS #
Overall 2 of 11
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 2 of 11
State (Delaware) 1 of 1
Country (United States) 2 of 6
Year (2014) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-08-12 Great Lakes Drug Development

Brighton, Michigan, United States

Great Lakes Drug Development, Inc. is a provider of strategic, operational and interim management support for early drug development projects.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-01 XenologiQ

Canterbury, United Kingdom

XenologiQ is a quantitative systems pharmacology (QSP) consultancy provider.

Buy -
Mergr

Product

Company

Legal